The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
An update of prophylactic human papillomavirus L1 virus-like particle vaccine clinical trial results
Open accessAbstract
This review focuses on recent publications of clinical trials of two prophylactic Human Papillomavirus (HPV) vaccines: Gardasil® (Merck & Co., Whitehouse Station, NJ USA), a quadrivalent vaccine containing L1 virus-like particles (VLPs) of types −6, 11, 16, and 18, and Cervarix® (GlaxoSmithKline Biologicals, Rixensart, Belgium), a bivalent vaccine containing VLPs of types −16 and 18. In efficacy trials involving young women, both vaccines produced outstanding efficacy against primary and secondary endpoints associated with the vaccine type HPVs and were highly and consistently immunogenic. Both had excellent safety records and, as expected, the most frequent vaccine-related adverse was moderate injection site sequelae. No evidence of waning protection was observed after four years for endpoints examined ranging from incident infection to cervical intraepithelial neoplasia grade 3 associated with the vaccine type HPVs. Gardasil® was also highly efficacious at preventing vaginal/vulvar lesions and genital warts. However, neither vaccine demonstrated therapeutic efficacy against prevalent infections or lesions, regardless of the associated HPV type. Cervarix® has shown limited cross-protection against infection with specific closely related types while preliminary results of limited cross-protection have been presented for Gardasil®. As expected, more limited efficacy was noted for both vaccines when women with prevalent infection were included or end points associated with any HPV type were evaluated. Immunological bridging trials involving adolescent girls and boys were also recently published. For both vaccines, serum VLP antibody levels in girls were non-inferior to those generated in young women and antibody response to Gardasil® was also non-inferior in boys. The results of these studies have led to the approval of Gardasil® and Cervarix® by national regulatory agencies in a number of countries.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases
Garland, S. M., Hernandez-Avila, M., Wheeler, C. M., Perez, G., Harper, D. M., Leodolter, S., Tang, G. W. K., Ferris, D. G., Steben, M., Bryan, J., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa061760 · Cited by 1,886
Cited by
Virus-like particles in vaccine development
Roldão, A., Mellado, M. C. M., Castilho, L. R., Carrondo, M. J., & Alves, P. M. (2010) · Expert Review of Vaccines · doi:10.1586/erv.10.115 · Cited by 845
A review of clinical trials of human papillomavirus prophylactic vaccines
Schiller, J. T., Castellsagué, X., & Garland, S. M. (2012) · Vaccine · doi:10.1016/j.vaccine.2012.04.108 · Cited by 747
Self-citationOpisthorchiasis and Opisthorchis-associated cholangiocarcinoma in Thailand and Laos
Sripa, B., Bethony, J. M., Sithithaworn, P., Kaewkes, S., Mairiang, E., Loukas, A., Mulvenna, J., Laha, T., Hotez, P. J., & Brindley, P. J. (2011) · Acta Tropica · doi:10.1016/j.actatropica.2010.07.006 · Cited by 347
Food-Borne Trematodiases in Southeast Asia
Sripa, B., Kaewkes, S., Intapan, P. M., Maleewong, W., & Brindley, P. J. (2010) · Advances in Parasitology · doi:10.1016/s0065-308x(10)72011-x · Cited by 339
Current understanding of the mechanism of HPV infection
Schiller, J. T., Day, P. M., & Kines, R. C. (2010) · Gynecologic Oncology · doi:10.1016/j.ygyno.2010.04.004 · Cited by 332
Self-citation
Metadata
- Authors
- Schiller, J. T., Castellsagué, X., Villa, L. L., & Hildesheim, A.
- Venue
- Vaccine
- Publisher
- Elsevier BV
- Published
- 2008-08
- Volume
- 26
- Pages
- K53-K61
- ISSN
- 0264-410X (ISSN-L)
- OpenAlex
- W2029997802
- Cited by
- 334
- References
- 1
- FWCI
- 30.88
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: An update of prophylactic human papillomavirus L1 virus-like particle vaccine clinical trial results. https://app.cochat.ai/papers/10.1016/j.vaccine.2008.06.002
- The paper
- Schiller, J. T., Castellsagué, X., Villa, L. L., & Hildesheim, A. (2008). An update of prophylactic human papillomavirus L1 virus-like particle vaccine clinical trial results. Vaccine. https://doi.org/10.1016/j.vaccine.2008.06.002
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.